Table 2.
Parameters | COVID−, TUNEL<15 | COVID+, TUNEL<15 | COVID−, TUNEL>15 | COVID+, TUNEL>15 |
---|---|---|---|---|
Progressive motility (PR, %) | 60.00 [49.00–70.00] | 62.00 [56.00–67.00] | 53.00 [41.00–63.00] | 62.00 [49.00–68.00] |
Nonprogressive motility (NP, %) | 9.00 [8.00–11.00] | 10.00 [7.00–12.00] | 7.00 [6.00–11.00] | 7.50 [6.50–9.50] |
Immotility (IM, %) | 27.00 [21.00–35.00] | 26.00 [21.00–29.00] | 40.00 [26.00–46.00] | 28.50 [24.00–44.00] |
Round cells (106 cells/mL) | 0.20 [0.00–1.00] | 0.20 [0.10–1.40] | 0.20 [0.20–0.40] | 1.55 [0.60–3.00] * |
Normal morphology (%) | 4.00 [3.00–4.00] | 3.00 [3.00–5.00] | 3.00 [2.00–3.00] | 2 [1.00–3.00] |
Head defects (%) | 89.00 [87.00–93.00] | 89.00 [87.00–93.00] | 93.00 [91.00–95.00] | 93.00 [92.50–95.50] |
Midpiece defects (%) | 1.00 [0.00–2.50] | 1.00 [1.00–1.00] | 1.00 [0.00–1.00] | 1.00 [0.00–1.50] |
Tail defects (%) | 0.50 [0.00–1.00] | 1.00 [0.50–1.00] | 0.00 [0.00–1.00] | 0.0 [0.00–1.50] |
*—significant difference between the COVID−, TUNEL>15 and COVID+, TUNEL>15 groups (p ≤ 0.05).